Volume 19 (2024)
Volume 18 (2023)
Volume 17 (2022)
Volume 16 (2021)
Volume 15 (2020)
Volume 14 (2019)
Volume 13 (2018)
Volume 12 (2017)
Volume 11 (2016)
Volume 10 (2015)
Volume 9 (2014)
Volume 8 (2013)
Volume 7 (2012)
Volume 6 (2011)
Volume 5 (2010)
Volume 4 (2009)
Volume 3 (2008)
Volume 2 (2007)
Volume 1 (2006)
Protein Expression of NEK2, JMJD4, and REST in Clear Cell Renal Cell Carcinoma (ccRCC): Clinical, Pathological, and Prognostic Findings

Walid S. H. Elsayed; Ola Harb; Mohamed A Alabiad; Rema H. Faraj Saad; Amal Anbaig; Mohamed Alorinin; Rehab Hemeda; Mohamed Negm; Loay M Gertallah; Walled A Abdelhady; Ramadan M Ali

Volume 18, Issue 2 , April 2023, , Pages 180-192


  Background & Objective: Cells of renal cell carcinoma (RCC) are resistant to the most currently used chemotherapeutic agents and targeted therapies; hence, we evaluated the expression of NEK2, JMJD4, and REST in tissues of clear cell renal cell carcinoma (ccRCC) and benign nearby tissues of kidney ...  Read More

A Rare Case of Metastasis of Renal Clear Cell Carcinoma to the Thyroid Gland, Presenting as a Goiter Nodule, Three Years After Nephrectomy

Hedieh Moradi Tabriz; Arezoo Eftekhar-Javadi; Atiieh Zandnejadi

Volume 15, Issue 4 , October 2020, , Pages 342-345


  Thyroid gland metastatic tumors are rare in clinical practice. Clear cell RCC is one of common metastatic tumors to thyroid. We here reported a case of incidentally found clear cell renal carcinoma metastasis to the thyroid gland 3 years after nephrectomy, in the thyroidectomy procedure performed for ...  Read More

Sarcomatoid Chromophobe Renal Cell Carcinoma with Heterologous Component

Sushma Bharti; Gautam Ram Choudhary; Jyotsna Naresh Bharti; Garg Pawan Kumar; Arsha BS; Poonam Abhay Elhence

Volume 15, Issue 1 , January 2020, , Pages 56-60


  Clear cellrenal cell carcinoma (RCC) is the most common malignant renal tumor in adults, while chromophobe RCC (CRCC) is the third most common. Any subtypes of RCC can undergo sarcomatoid differentiation, but heterologous differentiation in sarcomatoid area is very rare in RCC. Here a61-year male is ...  Read More

Bone & Soft tissue Pathology
Duodenal Metastases From Renal Cell Carcinoma Presented With Melena: Review and Case Report

Ramesh Omranipour; Habibollah Mahmoudzadeh; Freshteh Ensani; Samira Yadegari; Seyed Rohollah Miri

Volume 12, Issue 3 , July 2017, , Pages 272-276


  Renal cell carcinoma (RCC) metastasis to duodenum is very rare and only a few case reports are available in the literature. We here reported a patient with solitary duodenal metastasis presented with melena six years after right nephrectomy. The patient underwent upper gastrointestinal endoscopy showing ...  Read More

Quick Score and H-Score Assessment of P504s (AMACR) Expression in Renal Cell Carcinoma (RCC) and Relation with Histologic Grade

Mahmoud Reza Kalantari; Tayyebeh Nazeran; Fatemeh Varshoee Tabrizi

Volume 7, Issue 3 , July 2012, , Pages 157-164

  Background and Aims: P504S (AMACR) is a mitochondrial enzyme expressed in renal cell carcinoma. Some of immunohistochemical markers in renal cell tumors are independent prognostic factor and show relation with histologic grading. AMACR expression increases with higher histological grading in different ...  Read More

Expression Of P53 And Ki67 Proteins In Renal Cell Carcinoma And Its Relationship With Nuclear Grade

Sakineh Amouian; Mahdi Farzadnia; Bahram Memar; Armin Attaranzadeh; Naser Tayyebi

Volume 3, Issue 1 , January 2008, , Pages 25-29

  Background and Objective: Evaluation of tumor proliferative activity may provide a predicting parameter to estimate biologic aggression and a subsequent prognosis that has been evaluated in many malignancies. We have selected renal cell carcinoma (RCC) in this study. To determine tumor proliferative ...  Read More

Prognostic value of p53 in renal cell carcinoma

Mahmoud Kabiri; Mehrdad Mohammadi Sichani; Mohammad Reza Mohajery; Diana Taheri; Ali Chehrei

Volume 1, Issue 2 , April 2006, , Pages 75-80

  Background and Objectives: RCC is one of the most common genitourinary cancers. Accurate prediction of prognosis would be valuable for adjuvant trial design, counseling and effectively scheduling follow up visits. P53 is a tumor suppressor gene that expresses a protein that involved in both cell-cycle ...  Read More